These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19105708)

  • 41. Misconduct trouble brewing in Göttingen.
    Birmingham K
    Nat Med; 2001 Aug; 7(8):875. PubMed ID: 11479600
    [No Abstract]   [Full Text] [Related]  

  • 42. Cancer vaccines on the horizon.
    Jones D
    Nat Rev Drug Discov; 2007 May; 6(5):333-4. PubMed ID: 17539052
    [No Abstract]   [Full Text] [Related]  

  • 43. Technical challenges facing therapeutic cancer vaccines.
    Ward S; Copier J; Dalgleish A
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):168-77. PubMed ID: 18283604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal.
    Rosenthal R; Viehl CT; Guller U; Weber WP; Adamina M; Spagnoli GC; Heberer M; Zuber M
    J Am Coll Surg; 2008 Jul; 207(1):95-105. PubMed ID: 18589368
    [No Abstract]   [Full Text] [Related]  

  • 45. Improving the efficacy of cancer immunotherapy.
    Copier J; Dalgleish AG; Britten CM; Finke LH; Gaudernack G; Gnjatic S; Kallen K; Kiessling R; Schuessler-Lenz M; Singh H; Talmadge J; Zwierzina H; Håkansson L
    Eur J Cancer; 2009 May; 45(8):1424-31. PubMed ID: 19167214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate.
    Soleimani A; Berntsen A; Svane IM; Pedersen AE
    Scand J Immunol; 2009 Nov; 70(5):481-9. PubMed ID: 19874553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Technology evaluation: Onyvax-P, Onyvax.
    Doehn C; Böhmer T; Jocham D
    Curr Opin Mol Ther; 2005 Oct; 7(5):511-9. PubMed ID: 16248287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphoma vaccine trial: one step forward in long trek.
    Schmidt C
    J Natl Cancer Inst; 2009 Sep; 101(18):1228-9, 1232. PubMed ID: 19738162
    [No Abstract]   [Full Text] [Related]  

  • 49. Novel strategies for improved cancer vaccines.
    Chen X; Chang CH; Goldenberg DM
    Expert Rev Vaccines; 2009 May; 8(5):567-76. PubMed ID: 19397414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trial watch: pivotal oncology trials: outlook for Q2 2009.
    Nehring R
    Nat Rev Drug Discov; 2009 Apr; 8(4):266. PubMed ID: 19337264
    [No Abstract]   [Full Text] [Related]  

  • 51. Statistical and trial design considerations in central nervous system prophylaxis studies.
    Smith JA; Glantz M
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S69-76. PubMed ID: 19660685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinth.
    Grange JM; Krone B; Stanford JL
    Eur J Cancer; 2009 Sep; 45(13):2266-73. PubMed ID: 19497734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapeutics in development for prostate cancer.
    Harzstark AL; Small EJ
    Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of dendritic cells in cancer therapy.
    Jefford M; Maraskovsky E; Cebon J; Davis ID
    Lancet Oncol; 2001 Jun; 2(6):343-53. PubMed ID: 11905751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No end in sight for German misconduct probe.
    Kerstholt M
    Nature; 2002 May; 417(6884):6. PubMed ID: 11986633
    [No Abstract]   [Full Text] [Related]  

  • 56. [Non-Hodgkin's lymphoma: personalized therapy with plants].
    Reichwein S; Warzecha H
    Pharm Unserer Zeit; 2008; 37(6):448. PubMed ID: 18956355
    [No Abstract]   [Full Text] [Related]  

  • 57. Heat-shock protein-based vaccines for cancer and infectious disease.
    Binder RJ
    Expert Rev Vaccines; 2008 Apr; 7(3):383-93. PubMed ID: 18393608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Towards the individualisation of prescriptions in oncology: urogenital cancers].
    Pouessel D; Culine S
    Bull Cancer; 2008 Oct; 95(10):975-8. PubMed ID: 19004728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reader comments on patient-specific vaccine therapy for non-Hodgkin lymphoma.
    Buchsel P; DeMeyer ES
    Clin J Oncol Nurs; 2005 Jun; 9(3):288; author reply 288. PubMed ID: 15973837
    [No Abstract]   [Full Text] [Related]  

  • 60. Cancer prevention: from 1727 to milestones of the past 100 years.
    Lippman SM; Hawk ET
    Cancer Res; 2009 Jul; 69(13):5269-84. PubMed ID: 19491253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.